(Q35576405)

8 August 2017

1 reference

title

Is weight reduction an effective therapy for nonalcoholic fatty liver? A systematic review (English)

1 reference

8 August 2017

1 reference

2

Ronald L Koretz

1 reference

8 August 2017

Rex T Wang

1

1 reference

8 August 2017

Hal F Yee

series ordinal

3

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

American Journal of Medicine

8 August 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

8 August 2017

volume

115

1 reference

8 August 2017

issue

7

1 reference

8 August 2017

page(s)

554-559

1 reference

Review: nonalcoholic steatohepatitis

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900449-2

Nonalcoholic Steatohepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900449-2

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900449-2

Nonalcoholic steatohepatitis: a study of 49 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900449-2

The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900449-2

Nonalcoholic steatohepatitis: An expanded clinical entity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900449-2

Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900449-2

Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900449-2

Metabolic and nutritional considerations in nonalcoholic fatty liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900449-2

Treatment of nonalcoholic fatty liver: present and emerging therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900449-2

Intestinal bypass surgery for morbid obesity. Long-term results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900449-2

Effect of weight control on hepatic abnormalities in obese patients with fatty liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900449-2

Therapeutic effects of restricted diet and exercise in obese patients with fatty liver.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900449-2

Liver morphology and function tests in obesity and during total starvation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900449-2

Nonalcoholic steatohepatitis in obesity: a reversible condition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900449-2

Regression of liver steatosis following gastroplasty or gastric bypass for morbid obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900449-2

Hepatic effects of dietary weight loss in morbidly obese subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900449-2

Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900449-2

Fatty liver--an additional and treatable feature of the insulin resistance syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900449-2

Effect of weight reduction on hepatic abnormalities in overweight patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900449-2

Steatosis and cirrhosis in an obese diabetic. Resolution of fatty liver by fasting.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900449-2

Three cases of comprehensive dietary therapy and pharmacotherapy of patients with complex obesity-related diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900449-2

AGA technical review on nonalcoholic fatty liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900449-2

Cardiovascular Changes After Weight Reduction in Obesity Hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900449-2

Weight gain as a risk factor for clinical diabetes mellitus in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900449-2

10.1016/S0002-9343(03)00449-2

7 January 2021

Identifiers

DOI

1 reference

8 August 2017

1 reference